Get started
Author

Anamarija Pfeiffer

ORCID: 0000-0002-1269-3321
Observed ORCID: 0000-0002-1269-3321
OpenAlex ID: A5015750381
Large-Scale Phosphoproteomics Reveals Shp-2 Phosphatase-Dependent Regulators of Pdgf Receptor Signaling
2018 · Tanveer S. Batth, Moreno Papetti, et al. · Cell Reports · 67
PDF
Time-resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling
2021 · Vidyasiri Vemulapalli, Lily A Chylek, et al. · eLife · 41
Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2022 · Anamarija Pfeiffer, Giulia Franciosa, et al. · Cancer Research · 24
PDF
Proteomic investigation of Cbl and Cbl-b in neuroblastoma cell differentiation highlights roles for SHP-2 and CDK16
2021 · Anna-Kathrine Pedersen, Anamarija Pfeiffer, et al. · iScience · 15
PDF
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer
2025 · Anamarija Pfeiffer, Luca Di Leo, et al. · International Journal of Molecular Sciences · 3
PDF
Abstract 4261: High-sensitivity HLA-I immunopeptidome profiling from limited clinical PBMC samples
2026 · Anamarija Pfeiffer, Lucy Yang, et al. · Cancer Research · 1
Abstract 5729: Discovery of tumor-specific antigens in melanoma tissue biopsies via integrated proteogenomic analysis
2026 · Arthur Viodé, Daniel Gautheret, et al. · Cancer Research
Abstract 2438: Discovery of predictive circulating proteomic biomarkers for therapy response in HRR-driven solid tumors
2026 · Anamarija Pfeiffer, Wouter van Bergen, et al. · Cancer Research
Abstract 7663: Discovery of tumor-specific and neoantigenic peptides in cancer tissue samples using mass spectrometry-based immunopeptidomic.
2026 · Cameron Ellis, Arhur Viodé, et al. · Cancer Research
Abstract 1768: High-sensitivity targeted mass spectrometry enables quantification of HLA-presented antigens for TCR-T therapeutic target discovery
2026 · Simonas Savickas, Anamarija Pfeiffer, et al. · Cancer Research
Abstract 5838: Quantification of ERAP-1 inhibition-dependent HLA-I peptides using targeted mass spectrometry for TCR-based therapeutics target discovery
2025 · Anamarija Pfeiffer, Lucy Yang, et al. · Cancer Research
Abstract 7238: Quantitative profiling of HLA class I and II antigens and neoantigens in tissue and PBMC samples with an improved mass spectrometry approach
2025 · Arthur Viodé, Anamarija Pfeiffer, et al. · Cancer Research
Modulation of antigen presentation by first-in-class ERAP1 and ERAP2 inhibitors for the treatment of cancer and autoimmunity
2024 · Kristopher Clark, Kate Anderton, et al. · The Journal of Immunology
Zinpentraxin Alfa Reduces Myelofibrosis in a JAK2-V617F Mouse Model of Myeloproliferative Neoplasms
2023 · Shivam Rai, Hui Hao-Shen, et al. · Blood
PDF
Data from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
Supplementary Table from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
Supplementary Table from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Supplementary Data from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
Supplementary Figure from Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
2023 · Anamarija Pfeiffer, Giulia Franciosa, et al.
PDF
Works count: 39
Citation count: 151
H-index: 4
I10-index: 4
Year
Topic
Type